Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, which has agreed to buy the ...
Russian billionaire Potanin acquires minority stake in cloud provider Selectel A joint venture controlled by Russian billionaire Vladimir Potanin has acquired a 25% stake in IT infrastructure provider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback